Analysis for DOW

📈 Growth & Financial Trajectory

Across the eight observed quarters, revenue rose from about $10.88B in 2024 Q1 to $12.09B in 2026 Q2, despite mid-cycle volatility. Net income progressed from roughly $538M in 2024 Q1 to $802M in 2026 Q2, with occasional losses in 2025 reflecting sector cyclicality.

The trend suggests a gradually improving top line and a more favorable margin mix by 2026, supported by positive operating income in the latest quarter.

💰 Margins & Cash Flow

Gross profit expanded from about $671M on $10.88B revenue in 2024 Q1 to $2.167B on $12.092B in 2026 Q2, implying gross margins rising from ~6% to ~18%. Operating income turned positive in 2026 Q2 and cash flow from operating activities remained robust in recent quarters (e.g., $1.33B in 2026 Q2). Free cash flow was pressured by investing activity, with investing cash flow consistently negative, while financing activity varied.

🛡️ Balance Sheet & Liquidity

Total assets ~ $61.6B versus liabilities ~ $44.2B; equity attributable to parent ~ $17.4B. Current assets to current liabilities ~ 1.75x indicate solid near-term liquidity. Leverage remains moderate (liabilities to assets ~ 0.72).

⚠️ Key Drivers & Risks

• Drivers: Industrial demand for chemicals and resilient petrochemical/margin recovery supports revenue and gross margin expansion.
• Risks: Sector cyclicality and commodity-price sensitivity; macro uncertainty and FX exposure could impact earnings and cash flow.